Statistical Designs for Pharmaceutical


Statistical Designs for Pharmaceutical

Drug Designing: Open Access is a scientific open access journal that specifies and describes the development activities conducted in the fields of including molecular modeling, clinical research and drug discovery and delivery.

In recent years, the concept of quality by design in (global) pharmaceutical development has received much attention. The purpose is to ensure that the compound under investigation will possess good drug characteristics such as identity, strength, purity, quality, safety, efficacy and stability before and post approval. A pharmaceutical development process consists of non-clinical (process validation and stability testing), pre-clinical animal and bioavailability/bioequivalence studies), and clinical (phases 1-3 clinical trials) development. In this article, various statistical designs that are commonly considered for achieving desired good drug characteristics as described in the United States Pharmacopeia and National Formulary at various stages of non-clinical, pre-clinical, and clinical development are reviewed. In addition, the possible use of innovative adaptive clinical trial designs that may lead to (i) the identification of any signals, trends/patterns, and optimal clinical benefits of a test treatment under investigation, and (ii) increase the probability of success of the development process with limited resources available are discussed.

This scientific journal includes a wide range of fields in its discipline to create a platform for the authors to make their contribution towards the journal and the editorial office at Longdom Publishing promises a peer review process for the submitted manuscripts to maintain the quality of free journals. The journal is among the best open access journals and aims to publish most complete and reliable source of information on the discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in all areas of the field.

How to submit:

Manuscripts can be submitted through the Editorial Tracking System or  as an e-mail attachment to the Editorial Office at

How we work:

We are using Editor Manager System for easy online tracking and managing of the manuscript processing. Each article undergoes a peer review process under the aegis of an assigned Editor. To be acceptable for publication, an article should be positively considered by two individual reviewers followed by the Editor’s consent.

  • After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.
  • A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted.
  • Manuscript will be published within 7days of acceptance.


Sherry Peterson

Journal Manager

Journal of Drug Designing: Open Access

 WhatsApp: +1-947-333-4405